faneotrics-2019-scientifictracks

3 / 10

conferenceseries.com
Volume 5 Neonatal and Pediatric Medicine Faneotrics 2019
March 21-22, 2019
Page 28
Notes:
March 21-22, 2019 Dubai, UAE
28th World Neonatal, Pediatric and Family
Medicine Conference
Challenges in the management of short stature
Nashwa Mohamed Baha Elddin
Cairo University, Egypt
Human growth is regulated by genetic, hormonal, nutritional and environmental factors that interact to culminate in a
complex process of cell replication in all tissues. Short stature is defined as height below 3rd centile or less than two Standard
Deviations (SDs) below the median height for that age and sex according to the population standard or even if the height is
within the normal percentiles but growth velocity is consistently below 25th percentile over 6-12 months of observation. It is
estimated that short stature to be around 3-5%. The prevalence of Growth Hormone Deficiency (GHD) is around 1 in 4,000.
Evidence-based procedures, relating specifically to height screening for identification of short stature, auxological criteria for
patient referral from primary to secondary pediatric care and general and endocrine investigations and diagnosis should be
followed. The Guidelines for Growth Hormone and Insulin-Like Growth Factor-1 Treatment in Children and Adolescents.
The rationale for treating short stature in childhood includes increasing height and alleviating psychosocial disability while
maintaining favorable risk, benefit and cost, benefit ratios. Selection among management options may therefore depend on the
degree to which each one meets these goals.
Biography
Nashwa Mohamed Baha Elddin has completed her MBBCh at Cairo University, Egypt in 1989 and Master’s degree in Pediatrics from the same university in 1995.
In 2005, she received her MD degree in Pediatric and Neonatal Medicine from Ain Shams University, Egypt. She worked as a Consultant Pediatric Endocrinology
and Diabetes in Egyptian health insurance hospitals and in Cairo University Pediatric Hospital (CUPH-Abo El Rish). In 2006, she moved to UAE and continued her
practice as Head of Pediatric Department in private hospitals in Abu Dhabi. She has participated in academic researches, in international and national conferences,
and has gained clinical attachment with Wilford Hall Hospital, USA. Currently, she is a Member of the European Society for Pediatric Endocrinology, Egyptian
Pediatric Association, Egyptian Society of Pediatric Endocrinology and Diabetes, Egyptian Obesity Association and Egyptian Society of Child Care Assistance to
Young Diabetics.
Nashwa Mohamed Baha Elddin, Neonat Pediatr Med 2019, Volume 5
DOI: 10.4172/2572-4983-C1-011